About the UVM Cancer Center

The University of Vermont (UVM) Cancer Center was founded in 1974. The cancer center is a not-for-profit organization administratively located at the Larner College of Medicine with clinical partnerships across the University of Vermont Health Network and beyond.

Mission

The mission of the University of Vermont Cancer Center is to reduce the burden of cancer in Vermont, northeastern New York and across northern New England, through research, outstanding clinical care, community outreach and education.

Vision

Working together, affiliated members, clinicians, scientists, and community stakeholders will be leaders in facilitating transdisciplinary discovery and achieving cancer health equity in northern New England.

The Four Pillars

The Cancer Center is a research institute, a clinical care facility, an educational entity and a community organization all in one. Our four pillars - research, clinical care, education, and community outreach - supports the mission of the Center -- to reduce the burden on cancer in the catchment area. 

The four pillars related to each other

Location & Facilities

The cancer center is an official administrative unit of UVM's Larner College of Medicine. Our clinicians enjoy a clinical partnership with the University of Vermont Medical Center. This flagship academic medical center includes an Ambulatory Care Center, an Education and Conference Center, and a cancer center clinical facility which allows integrated, multidisciplinary services for cancer diagnosis, outpatient treatment, and post-treatment follow up.

Communications

Innovations Newsletter 
View all issues
To receive a printed copy, email cancer@uvmcc.med.uvm.edu

Annual Report
2023 Annual Report | 2022 Annual Report

Patient Newsletter
Sign up form (bottom of the page)

X: @UVMcancercenter
Facebook: @UVMCancerCenter

YouTube: Playlist

Contact Us

The University of Vermont Cancer Center
The Courtyard at Given
4th Floor North
89 Beaumont Avenue
Burlington, VT  05405

Clinical contact: (802) 847-8400.

Administrative contact:

Phone: (802) 656-4414
Fax: (802) 656-8788
Email: cancer@uvmcc.med.uvm.edu

Chris Holmes, M.D., Ph.D. appointed Medical Director for Cancer Clinical Programs at the UVM Health Network

July 23, 2024 by Kate Strotmeyer

Chris Holmes, M.D., Ph.D.

The University of Vermont (UVM) Cancer Center and the UVM Health Network is pleased to announce the appointment of Chris Holmes, M.D., Ph.D. as Medical Director for Cancer Clinical Programs. Dr. Holmes, a Professor of Medicine at the University of Vermont’s Larner College of Medicine, is currently Deputy Division Chief for Hematology/Oncology at the University of Vermont Cancer Center. 

In her new role as Medical Director, Dr. Holmes will work closely with Kevin Vest, M.B.A. Network Vice President Cancer Clinical Programs, UVM Cancer Center Director, Randall Holcombe, M.D., M.B.A. as well as providers and leaders across multiple departments and divisions to coordinate cancer care across the network and ensure the highest quality of cancer care for patients.  Dr. Holmes succeeds H. James Wallace, M.D. who stepped down from this role on July 1.

“Dr. Holmes’ will be instrumental in enabling the University of Vermont Cancer Center to achieve its goals of exceptional clinical oncology care across all network sites,” said Dr. Holcombe. “Dr Holmes’ clinical and research experience make her uniquely situated for this leadership role. I look forward to working with her to further integrate our cancer clinical services to benefit patients and caregivers.” 

During her 24 years at UVM, Dr. Holmes has held many leadership positions. She is currently Deputy Division Chief for Hematology/Oncology, leader of the Hematologic Malignancies Transdisciplinary Team, and Medical Director of the Vermont Regional Hemophilia Treatment Center which serves the UVM Health Network, the state of Vermont, and Northern New York.  Dr. Holmes previously served in multiple roles for the UVM Cancer Center including interim co-director, deputy director, and associate director for clinical and translational research.  

“This is an exciting time of opportunity for cancer care in our health network,” said Dr. Holmes. “I am looking forward to continuing to work collaboratively across our sites to achieve our shared goal of compassionately delivering world class cancer care close to home for our patients in Vermont and northern New York.” 

Dr. Holmes received her Ph.D. and M.D. degrees from the University of Virginia and completed a residency in Internal Medicine and fellowship in Hematology/Oncology at the University of Vermont.  She was appointed as a faculty member in 2004. 

Dr. Holmes’ research program is focused on developing evidence-based, clinical interventions to reduce venous thrombosis and bleeding complications and improve mortality in patients with cancer. Her work has led to numerous high-impact publications and has been supported by funding from several sources, most recently an R21 grant from the National Institutes of Health.

Dr. Holmes brings extensive leadership experience in collaborative clinical and research initiatives to her new role, which she began on July 1, 2024.